MYOKARDIA INC's ticker is MYOK and the CUSIP is 62857M105. A total of 125 filers reported holding MYOKARDIA INC in Q2 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,094,000 | +53.2% | 37,367 | +8.6% | 0.02% | +17.6% |
| Q2 2020 | $3,324,000 | +602.7% | 34,403 | +240.8% | 0.02% | +466.7% |
| Q1 2020 | $473,000 | -64.6% | 10,094 | -60.6% | 0.00% | -40.0% |
| Q3 2019 | $1,335,000 | +42.2% | 25,615 | +41.8% | 0.01% | +25.0% |
| Q1 2019 | $939,000 | -85.6% | 18,059 | -86.5% | 0.00% | -86.2% |
| Q4 2018 | $6,518,000 | -34.1% | 133,416 | -12.0% | 0.03% | -19.4% |
| Q3 2018 | $9,887,000 | +88.3% | 151,653 | +43.4% | 0.04% | +63.6% |
| Q2 2018 | $5,252,000 | +27.5% | 105,773 | +25.3% | 0.02% | +15.8% |
| Q1 2018 | $4,118,000 | – | 84,387 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 399,360 | $54,445,000 | 40.54% |
| Copernicus Capital Management, LLC | 42,186 | $5,751,000 | 5.48% |
| Casdin Capital, LLC | 870,000 | $118,607,000 | 5.31% |
| Foresite Capital Management IV, LLC | 126,492 | $17,245,000 | 3.89% |
| Avoro Capital Advisors LLC | 1,885,000 | $256,982,000 | 3.65% |
| RTW INVESTMENTS, LP | 936,931 | $127,732,000 | 3.08% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 65,859 | $8,979,000 | 2.90% |
| Perceptive Advisors | 1,395,017 | $190,183,000 | 2.78% |
| Fernwood Investment Management, LLC | 38,547 | $5,255,000 | 2.48% |
| Grace Capital | 23,400 | $3,190,000 | 2.47% |